195 related articles for article (PubMed ID: 22509385)
1. Mixed adjuvant formulations reveal a new combination that elicit antibody response comparable to Freund's adjuvants.
Lai RP; Seaman MS; Tonks P; Wegmann F; Seilly DJ; Frost SD; LaBranche CC; Montefiori DC; Dey AK; Srivastava IK; Sattentau Q; Barnett SW; Heeney JL
PLoS One; 2012; 7(4):e35083. PubMed ID: 22509385
[TBL] [Abstract][Full Text] [Related]
2. Use of a polyanionic carbomer, Carbopol971P, in combination with MF59, improves antibody responses to HIV-1 envelope glycoprotein.
Dey AK; Burke B; Sun Y; Hartog K; Heeney JL; Montefiori D; Srivastava IK; Barnett SW
Vaccine; 2012 Apr; 30(17):2749-59. PubMed ID: 22366638
[TBL] [Abstract][Full Text] [Related]
3. Safety and immunogenicity of Env 2-3, a human immunodeficiency virus type 1 candidate vaccine, in combination with a novel adjuvant, MTP-PE/MF59. NIAID AIDS Vaccine Evaluation Group.
Keefer MC; Graham BS; McElrath MJ; Matthews TJ; Stablein DM; Corey L; Wright PF; Lawrence D; Fast PE; Weinhold K; Hsieh RH; Chernoff D; Dekker C; Dolin R
AIDS Res Hum Retroviruses; 1996 May; 12(8):683-93. PubMed ID: 8744579
[TBL] [Abstract][Full Text] [Related]
4. Neutralizing antibody responses to subtype B and C adjuvanted HIV envelope protein vaccination in rabbits.
Burke B; Gómez-Román VR; Lian Y; Sun Y; Kan E; Ulmer J; Srivastava IK; Barnett SW
Virology; 2009 Apr; 387(1):147-56. PubMed ID: 19249806
[TBL] [Abstract][Full Text] [Related]
5. Microparticles in MF59, a potent adjuvant combination for a recombinant protein vaccine against HIV-1.
O'Hagan DT; Ugozzoli M; Barackman J; Singh M; Kazzaz J; Higgins K; Vancott TC; Ott G
Vaccine; 2000 Mar; 18(17):1793-801. PubMed ID: 10699327
[TBL] [Abstract][Full Text] [Related]
6. Antibody responses after intravaginal immunisation with trimeric HIV-1 CN54 clade C gp140 in Carbopol gel are augmented by systemic priming or boosting with an adjuvanted formulation.
Cranage MP; Fraser CA; Cope A; McKay PF; Seaman MS; Cole T; Mahmoud AN; Hall J; Giles E; Voss G; Page M; Almond N; Shattock RJ
Vaccine; 2011 Feb; 29(7):1421-30. PubMed ID: 21187177
[TBL] [Abstract][Full Text] [Related]
7. Effects of Adjuvants on HIV-1 Envelope Glycoprotein SOSIP Trimers
Ozorowski G; Cupo A; Golabek M; LoPiccolo M; Ketas TA; Cavallary M; Cottrell CA; Klasse PJ; Ward AB; Moore JP
J Virol; 2018 Jul; 92(13):. PubMed ID: 29669838
[TBL] [Abstract][Full Text] [Related]
8. HIV-Exposed Infants Vaccinated with an MF59/Recombinant gp120 Vaccine Have Higher-Magnitude Anti-V1V2 IgG Responses than Adults Immunized with the Same Vaccine.
McGuire EP; Fong Y; Toote C; Cunningham CK; McFarland EJ; Borkowsky W; Barnett S; Itell HL; Kumar A; Gray G; McElrath MJ; Tomaras GD; Permar SR; Fouda GG
J Virol; 2018 Jan; 92(1):. PubMed ID: 29021402
[TBL] [Abstract][Full Text] [Related]
9. Generation and characterization of a bivalent protein boost for future clinical trials: HIV-1 subtypes CR01_AE and B gp120 antigens with a potent adjuvant.
Wen Y; Trinh HV; Linton CE; Tani C; Norais N; Martinez-Guzman D; Ramesh P; Sun Y; Situ F; Karaca-Griffin S; Hamlin C; Onkar S; Tian S; Hilt S; Malyala P; Lodaya R; Li N; Otten G; Palladino G; Friedrich K; Aggarwal Y; LaBranche C; Duffy R; Shen X; Tomaras GD; Montefiori DC; Fulp W; Gottardo R; Burke B; Ulmer JB; Zolla-Pazner S; Liao HX; Haynes BF; Michael NL; Kim JH; Rao M; O'Connell RJ; Carfi A; Barnett SW
PLoS One; 2018; 13(4):e0194266. PubMed ID: 29698406
[TBL] [Abstract][Full Text] [Related]
10. The adjuvant AlhydroGel elicits higher antibody titres than AddaVax when combined with HIV-1 subtype C gp140 from CAP256.
van Diepen MT; Chapman R; Moore PL; Margolin E; Hermanus T; Morris L; Ximba P; Rybicki EP; Williamson AL
PLoS One; 2018; 13(12):e0208310. PubMed ID: 30557314
[TBL] [Abstract][Full Text] [Related]
11. DNA-MVA-protein vaccination of rhesus macaques induces HIV-specific immunity in mucosal-associated lymph nodes and functional antibodies.
Chege GK; Burgers WA; Müller TL; Gray CM; Shephard EG; Barnett SW; Ferrari G; Montefiori D; Williamson C; Williamson AL
Vaccine; 2017 Feb; 35(6):929-937. PubMed ID: 28069361
[TBL] [Abstract][Full Text] [Related]
12. Different adjuvanted pediatric HIV envelope vaccines induced distinct plasma antibody responses despite similar B cell receptor repertoires in infant rhesus macaques.
Berendam SJ; Morgan-Asiedu PK; Mangan RJ; Li SH; Heimsath H; Luo K; Curtis AD; Eudailey JA; Fox CB; Tomai MA; Phillips B; Itell HL; Kunz E; Hudgens M; Cronin K; Wiehe K; Alam SM; Van Rompay KKA; De Paris K; Permar SR; Moody MA; Fouda GG
PLoS One; 2021; 16(12):e0256885. PubMed ID: 34972105
[TBL] [Abstract][Full Text] [Related]
13. Prime-Boost Immunizations with DNA, Modified Vaccinia Virus Ankara, and Protein-Based Vaccines Elicit Robust HIV-1 Tier 2 Neutralizing Antibodies against the CAP256 Superinfecting Virus.
van Diepen MT; Chapman R; Douglass N; Galant S; Moore PL; Margolin E; Ximba P; Morris L; Rybicki EP; Williamson AL
J Virol; 2019 Apr; 93(8):. PubMed ID: 30760570
[TBL] [Abstract][Full Text] [Related]
14. Effects of adjuvants and multiple antigen peptides on humoral and cellular immune responses to gp160 of HIV-1.
Levi M; Rudén U; Birx D; Loomis L; Redfield R; Lövgren K; Akerblom L; Sandström E; Wahren B
J Acquir Immune Defic Syndr (1988); 1993 Aug; 6(8):855-64. PubMed ID: 8315572
[TBL] [Abstract][Full Text] [Related]
15. Potent adaptive immune responses induced against HIV-1 gp140 and influenza virus HA by a polyanionic carbomer.
Krashias G; Simon AK; Wegmann F; Kok WL; Ho LP; Stevens D; Skehel J; Heeney JL; Moghaddam AE; Sattentau QJ
Vaccine; 2010 Mar; 28(13):2482-9. PubMed ID: 20132920
[TBL] [Abstract][Full Text] [Related]
16. DNA prime-protein boost using subtype consensus Env was effective in eliciting neutralizing antibody responses against subtype BC HIV-1 viruses circulating in China.
Zhang M; Zhang L; Zhang C; Hong K; Shao Y; Huang Z; Wang S; Lu S
Hum Vaccin Immunother; 2012 Nov; 8(11):1630-7. PubMed ID: 23111170
[TBL] [Abstract][Full Text] [Related]
17. Antibody production in rabbits administered Freund's complete adjuvant and carprofen concurrently.
Fishback JE; Stronsky SM; Green CA; Bean KD; Froude JW
Lab Anim (NY); 2016 Feb; 45(2):63-6. PubMed ID: 26814352
[TBL] [Abstract][Full Text] [Related]
18. DNA vaccine molecular adjuvants SP-D-BAFF and SP-D-APRIL enhance anti-gp120 immune response and increase HIV-1 neutralizing antibody titers.
Gupta S; Clark ES; Termini JM; Boucher J; Kanagavelu S; LeBranche CC; Abraham S; Montefiori DC; Khan WN; Stone GW
J Virol; 2015 Apr; 89(8):4158-69. PubMed ID: 25631080
[TBL] [Abstract][Full Text] [Related]
19. A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques.
Jones AT; Chamcha V; Kesavardhana S; Shen X; Beaumont D; Das R; Wyatt LS; LaBranche CC; Stanfield-Oakley S; Ferrari G; Montefiori DC; Moss B; Tomaras GD; Varadarajan R; Amara RR
J Virol; 2018 Mar; 92(5):. PubMed ID: 29237847
[TBL] [Abstract][Full Text] [Related]
20. A comparative immunogenicity study in rabbits of disulfide-stabilized, proteolytically cleaved, soluble trimeric human immunodeficiency virus type 1 gp140, trimeric cleavage-defective gp140 and monomeric gp120.
Beddows S; Franti M; Dey AK; Kirschner M; Iyer SP; Fisch DC; Ketas T; Yuste E; Desrosiers RC; Klasse PJ; Maddon PJ; Olson WC; Moore JP
Virology; 2007 Apr; 360(2):329-40. PubMed ID: 17126869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
